靶向肿瘤KRAS 突变的T细胞过继免疫治疗
评价者:刘晓晴1, 范杰1, 文献合成者:黄淑梅2

T-Cell Transfer Immunological Therapy Targeting Mutant KRAS in Cancer
Reviewers:LIU Xiao-qing1, FAN Jie1, Literature Co-worker: HUANG Shu-mei2